AI Verdict
JRSH has stronger fundamentals based on our AI analysis.
JSPRW vs JRSH Fundamental Comparison
| Metric | JSPRW | JRSH |
|---|---|---|
| Revenue | $-246,000.0 | $123.4M |
| Net Income | $-75.8M | $2.0M |
| Net Margin | 30,813.4% | 1.6% |
| ROE | -1,826.1% | 3.1% |
| ROA | -211.9% | 2.3% |
| Current Ratio | 2.62x | 2.79x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-3.95 | $0.15 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JSPRW vs JRSH: Frequently Asked Questions
Is JSPRW or JRSH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JRSH has stronger fundamentals. JSPRW is rated STRONG SELL (85% confidence) while JRSH is rated SELL (78% confidence). This is not investment advice.
How does JSPRW compare to JRSH fundamentally?
Jasper Therapeutics, Inc. has ROE of -1,826.1% vs Jerash Holdings (US), Inc.'s 3.1%. Net margins are 30,813.4% vs 1.6% respectively.
Which stock pays higher dividends, JSPRW or JRSH?
JSPRW has a dividend yield of N/A or no dividend while JRSH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JSPRW or JRSH for long term?
For long-term investing, consider that JSPRW has STRONG SELL rating with 85% confidence, while JRSH has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JSPRW vs JRSH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JSPRW vs JRSH, the AI consensus favors JRSH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.